Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 10 Suppl 1 (Suppl 1), S15

Medical Nutrition Therapy: Use of Sourdough Lactic Acid Bacteria as a Cell Factory for Delivering Functional Biomolecules and Food Ingredients in Gluten Free Bread

Affiliations
Review

Medical Nutrition Therapy: Use of Sourdough Lactic Acid Bacteria as a Cell Factory for Delivering Functional Biomolecules and Food Ingredients in Gluten Free Bread

Elke K Arendt et al. Microb Cell Fact.

Abstract

Celiac disease (CD) is an immune-mediated disease, triggered in genetically susceptible individuals by ingesting gluten from wheat, rye, barley, and other closely related cereal grains. Currently, the estimated prevalence of CD is around 1 % of the population in the western world and medical nutritional therapy (MNT) is the only accepted treatment for celiac disease. To date, the replacement of gluten in bread presents a significant technological challenge for the cereal scientist due to the low baking performance of gluten free products (GF). The increasing demand by the consumer for high quality gluten-free (GF) bread, clean labels and natural products is rising. Sourdough has been used since ancient times for the production of rye and wheat bread, its universal usage can be attributed to the improved quality, nutritional properties and shelf life of sourdough based breads. Consequently, the exploitation of sourdough for the production of GF breads appears tempting. This review will highlight how sourdough LAB can be an efficient cell factory for delivering functional biomolecules and food ingredients to enhance the quality of gluten free bread.

Figures

Figure 1
Figure 1
The causes of celiac disease

Similar articles

See all similar articles

Cited by 11 PubMed Central articles

See all "Cited by" articles

References

    1. Goggins M, Kelleher D. Celiac disease and other nutrient related injuries to the gastrointestinal tract. Am J Gastroenterol. 1994;89(S2):17. - PubMed
    1. Catassi C, Kryszak D, Bhatti B, Sturgeon C, Helzlsouer K, Clipp SL, Gelfond D, Puppa E, Sferruzza A, Fasano A. Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann Med. 2010;42:530–8. doi: 10.3109/07853890.2010.514285. - DOI - PubMed
    1. Mustalahti K, Catassi C, Reunanen A, Fabiani E, Heier M, McMillan S, Murray L, Metzger MH, Gasparin M, Bravi E, Maki M. The prevalence of celiac disease in Europe: Results of a centralized, international mass screening project. Ann Med. 2010;42:587–595. doi: 10.3109/07853890.2010.505931. - DOI - PubMed
    1. Feighery C. Fortnightly review: coeliac disease. BMJ. 1999;319:236–9. - PMC - PubMed
    1. Murray JA. The widening spectrum of celiac disease. Am J Clin Nutr. 1999;69:354–65. - PubMed

Publication types

Feedback